These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6959074)

  • 1. [Morphological classification of acute myeloid leukemias using the FAB system. Retrospective analysis of 106 cases].
    Reiffers J; Dachary D; Bernard P; Veyret V; Boisseau MR; Broustet A
    Nouv Rev Fr Hematol (1978); 1982; 24(4):237-40. PubMed ID: 6959074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemistry of acute myeloid leukemias: an ultrastructural study by the immunogold method.
    Polli N; Meroni G; Soligo D; Cattoretti G; Maiolo AT; Lambertenghi-Deliliers G
    J Submicrosc Cytol; 1987 Jan; 19(1):185-92. PubMed ID: 3470529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current diagnosis of acute nonlymphoblastic leukemias].
    Frenkel' MA; Tupitsyn NN; Fleĭshman EV
    Ter Arkh; 1994; 66(7):7-10. PubMed ID: 7985136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
    Crisan D; David D; DiCarlo R
    Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classification of acute leukaemia (AL) and its clinical significance.
    Catovsky D; Tavares de Castro J
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1434-7. PubMed ID: 6359396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocellular acute myeloid leukemia: the Rochester (New York) experience.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Hematol Pathol; 1995; 9(3-4):195-203. PubMed ID: 8655464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemical and immunological phenotying of acute nonlymphoblastic leukemia in Thai patients.
    Pokatikorn W; Apibal S; Atichartakarn V; Sriurairatana S; Chiewsilp D; Thitikawin P; Timvipark C
    J Med Assoc Thai; 1996 Nov; 79(11):708-14. PubMed ID: 8997009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.
    Bennett JM; Begg CB
    Cancer Res; 1981 Nov; 41(11 Pt 2):4833-7. PubMed ID: 6945906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
    Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia.
    Matsuo T; Tomonaga M; Bennett JM; Kuriyama K; Imanaka F; Kuramoto A; Kamada N; Ichimaru M; Finch SC; Pisciotta AV
    Jpn J Clin Oncol; 1988 Jun; 18(2):91-6. PubMed ID: 2898029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.
    Harani MS; Adil SN; Shaikh MU; Kakepoto GN; Khurshid M
    J Ayub Med Coll Abbottabad; 2005; 17(1):26-9. PubMed ID: 15929522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes transducing extracellular signals in acute myeloid human leukemias.
    Losa GA; Leoni L; Grob JP
    Schweiz Med Wochenschr; 1993 Jan; 123(3):69-73. PubMed ID: 8093982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
    Al Safadi L; Köhler G; Schaefer HE
    Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of hypoplastic acute leukemia which transformed naturally from hypercellular bone marrow to hypocellular with reference to the atypical aplastic anemia (author's transl)].
    Nishio A; Nakanishi S; Kitamura M; Ashizawa H; Hamami T; Nakata T; Hosoda M; Haruyama H; Katsuki A; Sugishima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1981 Nov; 22(11):1743-50. PubMed ID: 6951065
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
    Davey FR; Erber WN; Gatter KC; Mason DY
    Am J Clin Pathol; 1988 Jan; 89(1):76-80. PubMed ID: 3422117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.